1. Pink Sheet
  2. >>Geography
  3. >>North America
  4. >>United States

Drug Shortage Bills Likely Drivers Of PDUFA Add-ons

 
• By Derrick Gingery

Rep. Burgess says there appears to be enough bipartisan support for dealing with the shortage problem that it almost certainly will be added to the reauthorizing legislation.

Drug shortage mitigation appears to be the leading issue that could be added onto the Prescription Drug User Fee Act reauthorization, according to Rep. Michael Burgess.

Burgess, a Texas Republican and vice chair of the House Energy and Commerce Subcommittee on Health, which has jurisdiction over PDUFA, said there appears to be enough bipartisan support for dealing with the shortage

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

More from North America

Recent and Upcoming FDA Advisory Committee Meetings

 
• By Sue Sutter

Recent and upcoming US FDA advisory committee meetings and a summary of the topics covered.

Most Favored Nation Pricing Policy Floated In Medicaid, Coming Back To Medicare?

 
• By Cathy Kelly

President Trump's ongoing interest in the policy, which would ensure the US government pays no more for prescription drugs than the lowest price available in comparable countries, continues to gain attention.

US FDA Advisory Committee Misperceptions Abound … At HHS

 
• By Michael McCaughan

HHS Secretary Robert F. Kennedy Jr. regularly decries the “conflicts of interest” he believes abound in advisory committees, but his concerns, as well as a recent “policy directive” eliminating industry representatives, seem driven by a misunderstanding of the panels’ jobs.